Nifedipine: more than a calcium channel blocker.
Nifedipine exhibits a greater incidence of side effects than the other currently marketed calcium channel antagonists. In addition to those effects attributable to calcium channel blockade, nifedipine produces side effects similar to the effects of adenosine. It is probable that nifedipine exerts part of its physiological actions through potentiation of adenosine. Adenosine, an endogenous calcium channel blocker, modifies synaptic events throughout the nervous system and causes sedation, smooth and skeletal muscle relaxation, anticonvulsion, hypotension and hypothermia, all reversible by caffeine or theophylline administration. Nifedipine inhibits adenosine uptake from, and release into, the extracellular space and binds at an adenosine receptor. Both nifedipine and adenosine interact with benzodiazepine binding sites. Interaction between nifedipine and adenosine should be kept in mind when treating patients with nifedipine.
D000241:Adenosine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D001569:Benzodiazepines / Q000037:antagonists & inhibitors / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology; D003327:Coronary Disease / Q000139:chemically induced / Q000503:physiopathology; D006801:Humans; D009543:Nifedipine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011956:Receptors, Cell Surface / Q000187:drug effects; D011983:Receptors, Purinergic
D011956:Receptors, Cell Surface; D011983:Receptors, Purinergic; D001569:Benzodiazepines; D002110:Caffeine; D009543:Nifedipine; D000241:Adenosine